anti-Wilms tumor gene 1 DNA vaccine (Wistar Institute/Inovio/Johns Hopkins University)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Nameanti-Wilms tumor gene 1 DNA vaccine (Wistar Institute/Inovio/Johns Hopkins University)
Drug Alias NameWT1 gene inhibitor DNA vaccines (Inovio)DNA vaccine (Wistar Institute/Inovio/Johns Hopkins University)
ClassificationVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccineVaccines > Application > Prophylactic vaccineVaccines > Application > Therapeutic vaccine
Mechanisms of ActionWilms' Tumour 1 inhibitors
TargetsWilms' Tumour 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Pennsylvania
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInovio Pharmaceuticals IncJohns Hopkins UniversityThe Wistar Institute Of Anatomy And Biology +[4] 
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A